What is the current m anagement of macular degeneration?

Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults. There are two main types of AMD: dry AMD and wet AMD.

Dry AMD is the most common type of AMD. It occurs when the macula, the central part of the retina, thins and becomes damaged. Dry AMD can cause blurred vision, difficulty seeing in low light, and loss of central vision.

Wet AMD is a less common but more serious type of AMD. It occurs when abnormal blood vessels grow under the macula. These blood vessels can leak blood and fluid, which can damage the macula and cause rapid vision loss.

The current management of AMD includes:

* Anti-VEGF therapy: Anti-VEGF drugs are injected into the eye to block the growth of abnormal blood vessels. This can help to prevent vision loss in people with wet AMD.

* Photodynamic therapy (PDT): PDT is a treatment that uses a light-activated drug to destroy abnormal blood vessels. PDT is sometimes used in combination with anti-VEGF therapy.

* Laser surgery: Laser surgery can be used to treat some cases of dry AMD and wet AMD. Laser surgery can help to reduce the amount of fluid in the macula and improve vision.

* Low-vision aids: Low-vision aids, such as magnifiers and telescopes, can help people with AMD to see better.

There is currently no cure for AMD, but these treatments can help to slow the progression of the disease and preserve vision.